GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Total Stockholders Equity

Rua Bioscience (NZSE:RUA) Total Stockholders Equity : NZ$6.27 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience Total Stockholders Equity?

Rua Bioscience's Total Stockholders Equity for the quarter that ended in Dec. 2024 was NZ$6.27 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Rua Bioscience's Book Value per Share for the quarter that ended in Dec. 2024 was NZ$0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Rua Bioscience's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.08.

Rua Bioscience Total Stockholders Equity Historical Data

The historical data trend for Rua Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience Total Stockholders Equity Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Total Stockholders Equity
30.98 24.20 20.12 6.77

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 26.69 20.12 9.48 6.77 6.27

Rua Bioscience  (NZSE:RUA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Rua Bioscience's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6.268-0)/214.848
=0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Rua Bioscience's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.44 + 0.073) / 6.268
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Rua Bioscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Total Stockholders Equity
Comparable Companies
ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904 BOM:532321
Traded in Other Exchanges
N/A
Address
1 Commerce Place, Awapuni, Gisborne, NZL, 4071
Website
https://www.ruabio.com
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany and New Zealand.

Rua Bioscience Headlines

No Headlines